Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Dependence of Optimal Histamine Release on Cell Surface IgE Density on Human Basophils: Nature of the Stimulus.

Nejad AS, MacGlashan DW Jr.

Int Arch Allergy Immunol. 2018;177(3):181-191. doi: 10.1159/000490152. Epub 2018 Aug 27.

PMID:
30149387
2.

Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab.

MacGlashan DW Jr, Saini SS.

J Allergy Clin Immunol. 2017 May;139(5):1680-1682.e10. doi: 10.1016/j.jaci.2016.12.965. Epub 2017 Mar 1. No abstract available.

PMID:
28259446
3.

Recovery from desensitization of IgE-dependent responses in human lung mast cells.

Lewis A, MacGlashan DW Jr, Suvarna SK, Peachell PT.

Clin Exp Allergy. 2017 Aug;47(8):1022-1031. doi: 10.1111/cea.12912. Epub 2017 Mar 31.

PMID:
28236656
4.

Differences in effects of omalizumab on late-phase responses to allergen challenge in the skin and nose at the time of basophil hyporesponsiveness.

Paterniti MO, Breslin LM, Courneya JP, Sterba PM, Hamilton RG, MacGlashan DW Jr, Saini SS.

J Invest Dermatol. 2014 Jun;134(6):1743-1744. doi: 10.1038/jid.2013.541. Epub 2013 Dec 23. No abstract available.

5.

Spontaneous basophil responses in food-allergic children are transferable by plasma and are IgE-dependent.

Schroeder JT, Bieneman AP, Chichester KL, Keet CA, Hamilton RG, MacGlashan DW Jr, Wood R, Frischmeyer-Guerrerio PA.

J Allergy Clin Immunol. 2013 Dec;132(6):1428-31. doi: 10.1016/j.jaci.2013.08.033. Epub 2013 Oct 17. No abstract available.

6.

Basophil activation testing.

MacGlashan DW Jr.

J Allergy Clin Immunol. 2013 Oct;132(4):777-87. doi: 10.1016/j.jaci.2013.06.038. Epub 2013 Aug 16.

PMID:
23958648
7.

Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.

Macglashan DW Jr, Saini SS.

J Allergy Clin Immunol. 2013 Oct;132(4):906-11.e1-4. doi: 10.1016/j.jaci.2013.04.056. Epub 2013 Jun 20.

8.

Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy.

Savage JH, Courneya JP, Sterba PM, Macglashan DW, Saini SS, Wood RA.

J Allergy Clin Immunol. 2012 Nov;130(5):1123-1129.e2. doi: 10.1016/j.jaci.2012.05.039. Epub 2012 Jul 15.

9.

Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors.

MacGlashan DW Jr, Savage JH, Wood RA, Saini SS.

J Allergy Clin Immunol. 2012 Nov;130(5):1130-1135.e5. doi: 10.1016/j.jaci.2012.05.038. Epub 2012 Jul 15.

10.

IgE-dependent signaling as a therapeutic target for allergies.

MacGlashan DW Jr.

Trends Pharmacol Sci. 2012 Sep;33(9):502-9. doi: 10.1016/j.tips.2012.06.002. Epub 2012 Jun 30. Review.

11.

Assessing basophil functional measures during monoclonal anti-IgE therapy.

Saini SS, MacGlashan DW Jr.

J Immunol Methods. 2012 Sep 28;383(1-2):60-4. doi: 10.1016/j.jim.2012.05.016. Epub 2012 Jun 1. Review.

12.

Glycomic analysis of human mast cells, eosinophils and basophils.

North SJ, von Gunten S, Antonopoulos A, Trollope A, MacGlashan DW Jr, Jang-Lee J, Dell A, Metcalfe DD, Kirshenbaum AS, Bochner BS, Haslam SM.

Glycobiology. 2012 Jan;22(1):12-22. doi: 10.1093/glycob/cwr089. Epub 2011 Jul 1.

13.

Cat allergen-induced blood basophil reactivity in vitro predicts acute human nasal allergen challenge responses in vivo.

Paterniti M, Kelly DC, Eckman JA, Sterba PM, Hamilton RG, Bochner BS, Macglashan DW Jr, Saini SS.

Clin Exp Allergy. 2011 Jul;41(7):963-9. doi: 10.1111/j.1365-2222.2011.03719.x. Epub 2011 Mar 29.

PMID:
21668817
14.

Characterization of syk expression in human lung mast cells: relationship with function.

Havard S, Scola AM, Kay LJ, Ishmael SS, MacGlashan DW Jr, Peachell PT.

Clin Exp Allergy. 2011 Mar;41(3):378-88. doi: 10.1111/j.1365-2222.2010.03667.x. Epub 2011 Jan 24.

PMID:
21255137
15.

Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab.

Zaidi AK, Saini SS, Macglashan DW Jr.

J Allergy Clin Immunol. 2010 Apr;125(4):902-908.e7. doi: 10.1016/j.jaci.2009.12.996. Epub 2010 Mar 17.

16.

IgE antibody-specific activity in human allergic disease.

Hamilton RG, MacGlashan DW Jr, Saini SS.

Immunol Res. 2010 Jul;47(1-3):273-84. doi: 10.1007/s12026-009-8160-3. Review.

PMID:
20066506
17.

Regulation of Fc epsilon RI expression during murine basophil maturation: the interplay between IgE, cell division, and Fc epsilon RI synthetic rate.

Zaidi AK, MacGlashan DW.

J Immunol. 2010 Feb 1;184(3):1463-74. doi: 10.4049/jimmunol.0901865. Epub 2009 Dec 30.

18.

Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.

Eckman JA, Sterba PM, Kelly D, Alexander V, Liu MC, Bochner BS, Macglashan DW Jr, Saini SS.

J Allergy Clin Immunol. 2010 Apr;125(4):889-895.e7. doi: 10.1016/j.jaci.2009.09.012. Epub 2009 Dec 4.

19.

Syk expression in peripheral blood leukocytes, CD34+ progenitors, and CD34-derived basophils.

Ishmael SS, MacGlashan DW Jr.

J Leukoc Biol. 2010 Feb;87(2):291-300. doi: 10.1189/jlb.0509336. Epub 2009 Nov 4.

20.

Self-termination/anergic mechanisms in human basophils and mast cells.

MacGlashan DW Jr.

Int Arch Allergy Immunol. 2009;150(2):109-21. doi: 10.1159/000218114. Epub 2009 May 11. Review.

21.

Expression of the high affinity IgE receptor by neutrophils of individuals with allergic asthma is both minimal and insensitive to regulation by serum IgE.

Mora J, Riggs EK, Fu J, MacGlashan DW Jr, Fox SA, Yu B, Tobin MC, Thomas LL.

Clin Immunol. 2009 Jul;132(1):132-40. doi: 10.1016/j.clim.2009.03.513. Epub 2009 Apr 8.

22.

A pH-stabilizing role of voltage-gated proton channels in IgE-mediated activation of human basophils.

Musset B, Morgan D, Cherny VV, MacGlashan DW Jr, Thomas LL, Ríos E, DeCoursey TE.

Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):11020-5. doi: 10.1073/pnas.0800886105. Epub 2008 Jul 29.

23.

Induced loss of Syk in human basophils by non-IgE-dependent stimuli.

MacGlashan DW Jr, Ishmael S, MacDonald SM, Langdon JM, Arm JP, Sloane DE.

J Immunol. 2008 Mar 15;180(6):4208-17.

24.

Distinct characteristics of signal transduction events by histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced priming and activation of human basophils.

Vonakis BM, Macglashan DW Jr, Vilariño N, Langdon JM, Scott RS, MacDonald SM.

Blood. 2008 Feb 15;111(4):1789-96. Epub 2007 Nov 27.

25.

Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement.

Yokoi H, Choi OH, Hubbard W, Lee HS, Canning BJ, Lee HH, Ryu SD, von Gunten S, Bickel CA, Hudson SA, Macglashan DW Jr, Bochner BS.

J Allergy Clin Immunol. 2008 Feb;121(2):499-505.e1. Epub 2007 Nov 26.

PMID:
18036650
26.

Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential A1 (TRPA1).

Taylor-Clark TE, Undem BJ, Macglashan DW Jr, Ghatta S, Carr MJ, McAlexander MA.

Mol Pharmacol. 2008 Feb;73(2):274-81. Epub 2007 Nov 13.

PMID:
18000030
27.

Endocytosis, recycling, and degradation of unoccupied FcepsilonRI in human basophils.

MacGlashan DW Jr.

J Leukoc Biol. 2007 Oct;82(4):1003-10. Epub 2007 Jul 3.

PMID:
17609340
28.
29.

Diagnostic tests based on human basophils: potentials, pitfalls and perspectives.

Kleine-Tebbe J, Erdmann S, Knol EF, MacGlashan DW Jr, Poulsen LK, Gibbs BF.

Int Arch Allergy Immunol. 2006;141(1):79-90. Epub 2006 Jul 11. Review.

PMID:
16837789
30.

Nasal sensory nerve populations responding to histamine and capsaicin.

Taylor-Clark TE, Kollarik M, MacGlashan DW Jr, Undem BJ.

J Allergy Clin Immunol. 2005 Dec;116(6):1282-8. Epub 2005 Oct 24.

PMID:
16337460
31.
32.

Expression of functional cysteinyl leukotriene receptors by human basophils.

Gauvreau GM, Plitt JR, Baatjes A, MacGlashan DW.

J Allergy Clin Immunol. 2005 Jul;116(1):80-7.

PMID:
15990778
33.

Role of chloride channels in bradykinin-induced guinea pig airway vagal C-fibre activation.

Lee MG, Macglashan DW Jr, Undem BJ.

J Physiol. 2005 Jul 1;566(Pt 1):205-12. Epub 2005 Apr 28.

34.

Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition.

Sloane DE, Tedla N, Awoniyi M, Macglashan DW Jr, Borges L, Austen KF, Arm JP.

Blood. 2004 Nov 1;104(9):2832-9. Epub 2004 Jul 8.

35.

Actin cytoskeleton-dependent down-regulation of early IgE-mediated signaling in human basophils.

Vilariño N, MacGlashan DW Jr.

J Leukoc Biol. 2004 May;75(5):928-37. Epub 2004 Mar 2.

PMID:
14996825
36.

Synthetic IgE peptide vaccine for immunotherapy of allergy.

Wang CY, Walfield AM, Fang X, Hammerberg B, Ye J, Li ML, Shen F, Shen M, Alexander V, MacGlashan DW.

Vaccine. 2003 Apr 2;21(15):1580-90.

PMID:
12639479
37.
39.
40.

Expression and modulation of FcepsilonRIalpha and FcepsilonRIbeta in human blood basophils.

Saini SS, Richardson JJ, Wofsy C, Lavens-Phillips S, Bochner BS, Macglashan DW Jr.

J Allergy Clin Immunol. 2001 May;107(5):832-41.

PMID:
11344350
41.

Human basophils: mediator release and cytokine production.

Schroeder JT, MacGlashan DW Jr, Lichtenstein LM.

Adv Immunol. 2001;77:93-122. Review. No abstract available.

PMID:
11293121
42.
43.
44.
45.

Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14-3D10.

Bheekha-Escura R, MacGlashan DW, Langdon JM, MacDonald SM.

Blood. 2000 Sep 15;96(6):2191-8.

47.

Intracellular expression and release of Fc epsilon RI alpha by human eosinophils.

Seminario MC, Saini SS, MacGlashan DW Jr, Bochner BS.

J Immunol. 1999 Jun 1;162(11):6893-900.

48.

Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor.

Bheekha-Escura R, Chance SR, Langdon JM, MacGlashan DW Jr, MacDonald SM.

J Allergy Clin Immunol. 1999 May;103(5 Pt 1):937-43.

PMID:
10329832
49.

Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo.

Saini SS, MacGlashan DW Jr, Sterbinsky SA, Togias A, Adelman DC, Lichtenstein LM, Bochner BS.

J Immunol. 1999 May 1;162(9):5624-30.

50.

Mechanisms and pharmacologic control of basophil-derived IL-4 and IL-13.

Schroeder JT, MacGlashan DW Jr, Lichtenstein LM.

Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):87-9.

PMID:
10224347

Supplemental Content

Loading ...
Support Center